What Characterizes Long-term Survivors of Recurrent Ovarian Cancer? Case Report and Review of the Literature.

Hilal, Ziad; Schultheis, Beate; Hartmann, Franziska; Dogan, Askin; Cetin, Cem; Krentel, Harald; Schiermeier, Sven; Tempfer, Clemens B

Hilal, Ziad; Schultheis, Beate; Hartmann, Franziska; Dogan, Askin; Cetin, Cem; Krentel, Harald; Schiermeier, Sven; Tempfer, Clemens B.

Afiliação

Hilal Z; Department of Obstetrics and Gynecology, Ruhr University Bochum, Bochum, Germany.
Schultheis B; Department of Hematology/Oncology, Ruhr University Bochum, Bochum, Germany.
Hartmann F; Department of Pathology, Ruhr University Bochum, Bochum, Germany.
Dogan A; Department of Obstetrics and Gynecology, Ruhr University Bochum, Bochum, Germany.
Cetin C; Department of Obstetrics and Gynecology, Ruhr University Bochum, Bochum, Germany.
Krentel H; Department of Obstetrics and Gynecology, St. Anna Hospital, Herne, Germany.
Schiermeier S; Department of Obstetrics and Gynecology, University of Witten/Herdecke, Witten, Germany.
Tempfer CB; Department of Obstetrics and Gynecology, Ruhr University Bochum, Bochum, Germany clemens.tempfer@rub.de.

Anticancer Res ; 36(10): 5365-5371, 2016 10.

Article em En | MEDLINE | ID: mdl-27798900

Assuntos

Recidiva Local de Neoplasia; Neoplasias Ovarianas/fisiopatologia; Sobreviventes; Feminino; Humanos; Pessoa de Meia-Idade; Neoplasias Ovarianas/tratamento farmacológico; Neoplasias Ovarianas/cirurgia

Palavras-chave

Ovarian cancer; chemotherapy; long-term survivor; recurrence; therapy response

Buscar no Google

Imprimir

XML

PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Sobreviventes / Recidiva Local de Neoplasia Tipo de estudo: Prognostic_studies Limite: Female / Humans / Middle aged Idioma: En Revista: Anticancer Res Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Alemanha

Buscar no Google

Imprimir

XML

PubMed Links